Abivax to be Added to Nasdaq Biotechnology Index PARIS, France – December 18, 2025 – 10:05 pm CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases, today announced that it will be added to the Nasdaq Biotechnology Index (Nasdaq: NBI), effective prior to mark ...

SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, beginning at approximately 10:30 a.m. (Pacific Standard Time) in San Francisco, CA. More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resmed.com. The ...

Reinforces Role of AI-Powered Quantitative Coronary Plaque AssessmentMOUNTAIN VIEW, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), announced the American College of Cardiology (ACC) and the American Heart Association (AHA) published new scientific statements supporting the prognostic value of quantifying coronary plaque and reinforcing the critical role of the coronary computed tomography angiography (CTA) ...

HIGH POINT, N.C., Dec. 18, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company, today announced a Phase 2 clinical study protocol developed in collaboration with M42’s Insights Research Organization & Solutions (IROS), a leading United Arab Emirates (UAE)-based contract research organization, has been submitted to the Department of Health (DOH) Abu Dhabi. The study is designed to evaluate the safety and efficacy of cadisegliatin, a potential first-in-class o ...

The TappAlpha SPY Growth & Daily Income ETF ( TSPY ) is emerging as an outperformer within the 0DTE S&P 500 based covered call ETFs. This outperformance has some structural origin in its methodology that should work well in flat market conditionsI am a stock analyst with over 20 years of experience in quantitative research, financial modeling, and risk management. My focus is on equity valuation, market trends, and portfolio optimization to uncover high-growth investment opportunities. As a former Vice Pres ...

Core Insights - Alphabet Inc. is actively investing in tech startups, exemplified by its recent investment in Lovable, a Swedish startup, during a $330 million Series B funding round, which values Lovable at $6.6 billion, tripling its valuation since July [2][3][6] - The company's stock performance is strong, with a current price of $302.21, reflecting a 1.85% increase, and a significant growth potential indicated by its 52-week high of $328.83 and low of $140.53 [4][6] - Alphabet's market capitalization stands at approximately $3.65 trillion, demonstrating its substantial presence in the market, with a trading volume of over 10 million shares, indicating active investor interest [5][6] Investment Strategy - Alphabet's investment in Lovable is part of a broader strategy to support promising tech startups, showcasing its commitment to fostering innovation within the tech ecosystem [2][3][6] - Notable investors in the Lovable funding round include Accel, Khosla Ventures, and Nvidia's NVentures, highlighting collaboration among major players in the tech industry [3][6] Market Position - Alphabet's stock performance and market capitalization reflect strong investor confidence in its future prospects, with robust trading activity indicating a positive outlook [5][6]

Looking for more? You NEED to get in the game!Get more with our playbook to significantly grow your wealth by embracing a blended trading and investing approach at our one-stop shop.If you act now and you can lock in 50% of savings versus the $1,668 some members pay, which will end this week. Get direct access to our fund traders today. Further, our HOLIDAY DEAL IS ON! Try us for one month for $77 versus the regular $199 price. Our results speak for themselves.You won't be disappointed when the gains roll i ...

Looking for more? You NEED to get in the game!Get more with our playbook to significantly grow your wealth by embracing a blended trading and investing approach at our one-stop shop.If you act now and you can lock in 50% of savings versus the $1,668 some members pay, which will end this week. Get direct access to our fund traders today. Further, our HOLIDAY DEAL IS ON! Try us for one month for $77 versus the regular $199 price. Our results speak for themselves.You won't be disappointed when the gains roll i ...

The AI bubble is already in the process of bursting; however, this is a very early stage ofAnalyst’s Disclosure:I/we have a beneficial short position in the shares of SPX either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no g ...

Key Takeaways MU posted fiscal Q1 2026 revenues of $13.64B, up 56.8% year over year, with profits beating estimates.MU benefited from strong AI-driven demand for high-bandwidth memory, keeping HBM supply tight.MU guided Q2 revenues of $18.3B-$19.1B and reported record $3.9B free cash flow in Q1.As 2026 draws closer, investors are actively seeking stocks poised to benefit from the artificial intelligence (AI) boom. Micron Technology, Inc. (MU) stands out given its recent strong quarterly results. So, does th ...